Page 3 - Upstream Processing News Today

Life science group Sartorius will acquire French company Polyplus for around €2.4bn ($2.6bn).

Samsung Biologics will begin construction of Plant 5 within the first half of this year: marking the first facility for its second Bio Campus.

The report provides a comprehensive analysis of the impact of the pandemic across the industry and an overview of the market scenario after COVID-19.

Several companies are involved in strategic alliances to boost their offerings in the space, that is projected to strengthen the market competition during...

/PRNewswire/ -- The "Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration),...

/PRNewswire/ -- The "Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration),...

A new vaccine manufacturing plant was opened in Cape Town by South Africa president Cyril Ramaphosa yesterday.

Orgenesis and The Johns Hopkins University will construct a cell and gene therapy processing facility for point of care treatment of patients at Johns Hopkins.

Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.

DUBLIN--(BUSINESS WIRE)--The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added to ResearchAndMarkets.com's offering.The publisher's research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturin...